Charles R Schaller - Net Worth and Insider Trading
Charles R Schaller Net Worth
The estimated net worth of Charles R Schaller is at least $9,001 dollars as of 2024-11-13. Charles R Schaller is the Director of Celldex Therapeutics Inc and owns about 333 shares of Celldex Therapeutics Inc (CLDX) stock worth over $9,001. Details can be seen in Charles R Schaller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles R Schaller has not made any transactions after 2010-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles R Schaller
Charles R Schaller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles R Schaller owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of Charles R Schaller’s form 4 insider trades.
Insider Ownership Summary of Charles R Schaller
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2010-09-09 | director |
Charles R Schaller Latest Holdings Summary
Charles R Schaller currently owns a total of 1 stock. Charles R Schaller owns 333 shares of Celldex Therapeutics Inc (CLDX) as of September 9, 2010, with a value of $9,001.
Latest Holdings of Charles R Schaller
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2010-09-09 | 333 | 27.03 | 9,001 |
Holding Weightings of Charles R Schaller
Charles R Schaller Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles R Schaller has made a total of 0 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years. The most-recent trade in Celldex Therapeutics Inc is the acquisition of 333 shares on September 9, 2010, which cost Charles R Schaller around $17,250.
Insider Trading History of Charles R Schaller
- 1
Charles R Schaller Trading Performance
GuruFocus tracks the stock performance after each of Charles R Schaller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles R Schaller is 15.58%. GuruFocus also compares Charles R Schaller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles R Schaller within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles R Schaller's insider trading performs compared to the benchmark.
Performance of Charles R Schaller
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.03 | | | | | |
| Relative Return to S&P 500(%) | -3.89 | | | | | |
Charles R Schaller Ownership Network
Ownership Network List of Charles R Schaller
Ownership Network Relation of Charles R Schaller
Charles R Schaller Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Charles R Schaller is the director of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include director & President and CEO Anthony S Marucci , SVP & Chief Product Dev Officer Elizabeth Crowley , and SVP and CFO Samuel Bates Martin .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Charles R Schaller made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 11,500 shares, with a net purchase of 11,500 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 11,500 shares were bought by its insiders, resulting in a net sale of 342,060 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Charles R Schaller Mailing Address
Above is the net worth, insider trading, and ownership report for Charles R Schaller. Currently GuruFocus does not have mailing address information for Charles R Schaller.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
